CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Cardiac Ablation for the treatment of persistent Atrial Fibrillationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05477602
NCT05477602N/ACompleted

The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System (The CathVision ECGenius System)

CathVision ApS·observational·Posted Jul 28, 2022·Updated Jan 30, 2026

In Brief

An observational study evaluating Cardiac Ablation for the treatment of persistent Atrial Fibrillation for Atrial Fibrillation. Completed, enrolled 21 participants across 1 site.

Detailed Summary

Collect electrophysiological data during atrial fibrillation (AF) ablation procedures to assess the performance of a Signal Complexity Visualization algorithm designed to be integrated into the CathVision ECGenius® System.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 28, 2022
Enrollment StartJan 16, 2023
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 3.9 years ago

Interventions

Cardiac Ablation for the treatment of persistent Atrial Fibrillationprocedure

Patients undergoing cardiac ablation for the treatment of persistent atrial fibrillation